Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: A pilot randomized controlled trial in primary care.

Endocrinology, Diabetes & Metabolism
Thomas RouyardAlastair Gray

Abstract

To assess the feasibility in routine primary care consultation and investigate the effect on risk recall and self-management of a new type of risk communication intervention based on behavioural economics ("nudge-based") for people with Type 2 diabetes mellitus (T2DM). Forty adults with poorly controlled T2DM (HbA1c > 7.5%) were randomized to receive a personalized, nudge-based risk communication intervention (n = 20) or standard care (n = 20). Risk recall and self-management were evaluated at baseline and 12 weeks after the intervention. Both in terms of feasibility and acceptability, this new risk communication intervention was very satisfactory. Study retention rate after 12 weeks was very high (90%) and participants were highly satisfied with the intervention (4.4 out of 5 on the COMRADE scale). Although not powered to identify significant between-group effects, the intervention significantly improved risk recall after 12 weeks and intentions to make lifestyle changes (dietary behaviour) compared to standard care. This pilot study provides the first evidence of the feasibility of implementing in primary care a nudge-based risk communication intervention for people with T2DM. Based on the promising results observed, an adequ...Continue Reading

References

Sep 1, 1992·The British Journal of Clinical Psychology·T M Marteau, H Bekker
Jan 1, 1997·Psychological Bulletin·A J Rothman, P Salovey
Sep 27, 1974·Science·A Tversky, D Kahneman
Jan 10, 2008·Research in Nursing & Health·Melody A Hertzog
Jul 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·K G AsimakopoulouT C Skinner
Jul 29, 2008·Journal of General Internal Medicine·Joel M SchectmanJohn D Voss
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Kevin G VolppGeorge Loewenstein
Mar 3, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anastasia SouretiMark Cobain
Mar 12, 2010·Patient Education and Counseling·Mirta Galesic, Rocio Garcia-Retamero
Sep 8, 2011·Perspectives in Clinical Research·Sandeep K Gupta
Oct 14, 2011·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kristel M Gallagher, John A Updegraff
Sep 8, 2012·BMC Health Services Research·Lynn A NutiLaura P Sands
Oct 10, 2013·Journal of Health Economics·Arthur E AttemaOlivier I'Haridon
Oct 17, 2013·Psychology and Aging·Nancy M PetryShannon Byrne
Jun 25, 2014·Diabetes Research and Clinical Practice·W D StrainP M Paldánius
Nov 22, 2014·The Journal of Clinical Hypertension·Nancy M PetryWilliam B White
Aug 9, 2016·BMC Medical Informatics and Decision Making·David Spiegelhalter
Nov 20, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·T RouyardA Gray
Dec 15, 2016·Pilot and Feasibility Studies·Sandra M EldridgeUNKNOWN PAFS consensus group

❮ Previous
Next ❯

Citations

Nov 5, 2019·Journal of Behavioral Medicine·Molly B RichardsonJulia M Gohlke
Dec 4, 2019·Asia-Pacific Journal of Ophthalmology·Tien Y Wong, Charumathi Sabanayagam
Mar 4, 2021·Journal of Diabetes Science and Technology·Thomas RouyardAlastair Gray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.